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Abstract. – OBJECTIVE: Probiotics S. sali-
varius 24SMBc and S. oralis 89a comprised in 
the nasal spray Rinogermina are known to exert 
inhibition of harmful pathogens and ameliorate 
the outcome of patients with chronic upper air-
ways infections. In this study, for the first time, 
the effect of this formulation on the modulation 
of the microflora of healthy subjects was eval-
uated, with particular interest on pathobionts 
and pathogens present.   
PATIENTS AND METHODS: Metagenomic 
identification and quantification of bacterial 
abundances in healthy subjects were carried 
out by means of Ion Torrent Personal Machine. 
In particular, nasal swabs were sampled one, 
two and four weeks after seven days of treat-
ment with Rinogermina. 
RESULTS: The modulation of the abundance 
of pathobionts and pathogenic species (i.e., Co-
rynebacterium diphtheriae, Haemophilus parain-
fluenzae, Moraxella catarrhalis, Prevotella den-
ticola, Prevotella melaninogenica, Rothia den-
tocariosa, Staphylococcus aureus and Strepto-
coccus pseudopneumoniae) was characterized 
and a significant temporary decrease in their 
presence was identified. 
CONCLUSIONS: The beneficial effects of S. 
salivarius 24SMBc and S. oralis 89a nasal in-
take was assessed but seemed to be restrict-
ed in specific temporal windows. Thus it would 
be interesting to evaluate also this positive im-
pact of longer administration of this probiotic 
formulation.
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Introduction 
The human nasal cavity harbors a rich bacte-
rial ecosystem characterized and influenced both 
by the host itself and the environmental conditions 
to which it is exposed1,2. When the non-sterile air 
is inhaled, potential pathogens together with dust 
and environmental particles are firstly filtered 
and trapped by vibrissae placed in the nostrils. 
Subsequently, the local microbial flora plays a 
crucial role in protecting the host by preventing 
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the colonization of the nasal vestibule by airborne 
pathogens. Indeed, the nasal flora discourages the 
pathogens attachment by means of a mechanism 
called “competitive exclusion”, in which prokary-
otic cells must compete with their neighbors for 
space and resources3. Furthermore, the commen-
sal bacteria harbored in the nasal cavity stimulate 
the consistent secretion of a mucus layer or snot 
containing enzymes and immunoglobulins apt to 
stimulate the host immune system and impeding 
the spread of a disease4.
Different aerobic and anaerobic bacterial 
communities physiologically constitute the nasal 
microbiota. Staphylococcus spp., Haemophilus 
spp., Streptococcus spp., Moraxella spp., Neis-
seria spp., and Corynebacterium spp. are some 
of the commensal aerobic bacteria that inhabit 
the healthy human nasal cavity5; whereas were 
Prevotella spp., Porphyromonas spp., Fusobac-
terium spp., and Peptostreptococcus spp. are 
the most common anaerobic isolates6. However, 
when external events such as alterations of the 
environmental conditions (e.g., humidity, oxygen 
concentration, climate change, pollution, pollen, 
exposure to chemicals, etc.) or trauma alter the 
homeostasis, a progressive change in the phys-
iologic flora might occurs leading to a microbi-
al imbalance, called dysbiosis. This occurrence 
might increase the host susceptibility favoring the 
establishment of inflammatory, infectious or al-
lergic diseases7,8. In particular, pathobionts might 
switch from carriage to a pathological state com-
promising the individual welfare. Thus, there is 
the need to restore the levels of a healthy nasal 
microflora. A recent study investigated the use of 
a nasal spray containing a mixture of probiotics 
(Streptococcus salivarius 24SMBc and Strepto-
coccus oralis 89a, 98:2 ratio) to evaluate the safe-
ty of the treatment on the nasal flora of healthy 
subjects9. Indeed, the use of α-hemolytic strepto-
cocci as prophylaxis is now a promising emerging 
strategy being S. salivarius and S. oralis biosafe 
colonizers characterizing a healthy and balanced 
nasopharyngeal microbiota9,10.
Even if it was described the valuable role of the 
analyzed treatment in the reduction of the harmful 
pathogens and the increase of beneficial one, there 
is still the need to characterize these populations 
to have a deeper insight into the modulation of 
the described bacterial hub. With this aim, in the 
present study, the ability of S. salivarius 24SMBc 
and S. oralis 89a to modulate the nasal microbiota 
composition was evaluated through the analysis 
of abundance of the identified species. 
Patients and Methods
Patients Recruitment, Probiotics 
Administration, and Sample Collection
Twenty-three healthy volunteers (19-64 years 
old; 9 males and 11 females) were recruited to this 
study between January and February 2017. 
The exclusion criteria were (1) the antibiotic 
consumption within two months before the exper-
imental treatment and (2) the use of any medical 
devices or treatment for nasal congestion. Fur-
thermore, (3) subjects suffering from allergies to 
pollen, grasses, poplars and dust and also (4) in-
dividuals with sinusitis or rhinosinusitis were ex-
cluded. The volunteers had no pets in their homes, 
and they lived in the same geographical area, in 
a limit of 10 km from the Milan urban center in 
order to ensure that all the subject were exposed 
to similar climatic and environmental conditions 
(e.g., humidity, temperature, pollution, etc.).
All the enrolled volunteers were treated with 
a mixture of S. salivarius 24SMBc, and S. oralis 
89a suspended in a 98:2 ration in buffered isotonic 
solution with pH 7.0 composed by poly(ethylene 
glycol)–poly(propylene glycol) (PEG-PPG) copo-
lymer and PEG-14 Dimethicone (Rinogermina, 
DMG, Rome, Italy). The probiotic solution was 
administrated with two bilateral spray injections 
into each anterior nostril for a week, in the morn-
ing after personal care/washing. 
Samples were collected by means of sterile 
pernasal swabs in polypropylene tubes (Thermo 
Fisher, Waltham, MA, USA). In particular, the 
surface of the mucosa of the left anterior nos-
tril was sampled in a 1 cm depth from the outer 
edge. Per subject, four nasal swabs were collect-
ed according to the following experimental time 
points: (1) before the treatment, (2) 1 week, (3) 2 
weeks and (4) 1 month after the end of the treat-
ment with probiotics. Samples were collected at 
the Laboratory of Clinical Microbiology (Uni-
versity of Milan, Milan, Italy) and store at -80°C 
until the analyses performed 48 h after sampling.
DNA Extraction, 16S rRNA Amplification, 
and Sequencing
Bacterial genomic deoxyribonucleic acid 
(DNA) was extracted by means of the QIAamp 
DNA Mini Kit (Qiagen, Milan, Italy). Then, part 
of the 16S Ribosomal Ribonucleic Acid (rRNA) 
gene sequences were amplified using the 16S 
Metagenomics Kit (Life Technologies, Monza, It-
aly) to analyses of the microbial populations char-
acterizing the samples through the Ion Torrent 
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sequencing technology (Life Technologies, Mon-
za, Italy). The hypervariable regions of the 16S 
rRNA were amplified using the primer set V2-4-8 
and V3-6, 7-9 at the conditions reported in Table 
I using the SimpliAmp Thermal Cycler (Thermo 
Fisher, Waltham, MA, USA).
The quality of the obtained amplicon was as-
sessed by electrophoresis on a 2% agarose gel. 
Finally, the sequencing of the bacterial DNA was 
performed through the Personal Genome Ma-
chine, as previously described 11.
Ethic Statement
All the performed procedures were conformed 
to the Helsinki of 1975, as revised in 2000 and 
2008. The experimental protocols were approved 
by the internal review board of the IRCCS Galeazzi 
Orthopaedic Institute and by the Ethics Committee 
of the IRCCS Ospedale San Raffaele (MicroSP no. 
31/INT/2017, Milan, Italy). The study was conduct-
ed according to the International Council for Har-
monisation of Technical Requirements for Phar-
maceuticals for Human Use guidelines for Good 
Clinical Practice. Finally, all the enrolled patients 
were extensively informed about the purpose of 
the study and a written consent was obtained from 
each participant. At the beginning and at the end 
of the trial, volunteers were asked to fill a ques-
tionnaire reporting any adverse effects and nasal 
disorders related to the treatment with probiotics. 
Statistical Analysis
The raw abundances of the species of each op-
erational taxonomic unit (OTU) were firstly nor-
malized to 100,000 reads per sample. The signifi-
cant differences in microbial species were assessed 
through the nonparametric tests based on the Kru-
skal-Wallis and Wilcoxon rank-sum test, coupled 
with Dunn’s post-hoc test (R software v 3.3.1, USA). 
All data are expressed as means, and only the signif-
icant differences were reported in graphs; p-values 
< 0.05 were considered statistically significant. 
Results
During the experimental time course, no se-
vere side effects were recorded in any enrolled 
patients after the treatment with S. salivarius 
24SMBc and S. oralis 89a. In particular, only 
10% of the subject suffered from allergic cold, 
and 80% did not show any problems breathing. 
However, 90% of people reported nasal dripping 
immediately after the treatment administration. 
A total amount of 4,901,713 high-quality fil-
tered reads were obtained (126,674±552,453 per 
patients), clustered in OTUs and consequently clas-
sified into taxonomic ranks (phyla, classes, orders, 
families, genera, and species). The changes detect-
ed in the presence of corynebacteria species in the 
nasal microbiota composition were represented in 
Figure 1A. In particular, after an initial decrease 
one week after the treatment, Corynebacterium 
diphtheriae showed a progressive increase at T3 
with a peak registered one month after the treat-
ment. Even if the initial drop was also detected for 
Corynebacterium accolens, Corynebacterium du-
rum, Corynebacterium macginleyi, Corynebacte-
rium tuberculostearicum, these microorganisms 
had a progressive decrease starting from T3, es-
pecially concerning C. durum, C. macginleyi. A 
similar trend was observed in Staphylococcus 
spp. (Figure 1B) where the effects of Rinogermina 
seemed to affect the abundance of these bacteria, 
especially one week after the administration. How-
ever, the increase at T3 highlighted the positive 
effects of the probiotic intake on Staphylococcus 
warneri and Staphylococcus hominis, two benefi-
cial commensal strains. Although S. aureus was 
widely present in nares of enrolled subjects, a re-
duction in the abundance of this ubiquitous species 
was appreciable during all the experimental time 
points. More importantly, the synergistic action of 
S. salivarius 24SMBc and S. oralis 89a resulted in 
a reduction of S. aureus up to one month after the 
treatment. Concomitantly, after an initial decrease 
at T2, the treatment helped Staphylococcus epider-
midis to colonize nasal mucosae with a growing 
trend also a month after the probiotic intake. 
Due to the different abundance of streptococ-
ci, these bacteria were depicted in two graphs to 
appreciate also the differences in underrepresent-
ed species (Figure 2). Streptococcus tigurinus 
displayed a consistent increase in the colonization 
of the nostrils one week after the probiotic in-
take followed by a sudden drop at T3. In contrast, 
Streptococcus sanguinis, Streptococcus thermo-
philus, Streptococcus sinensis and Streptococcus 
Table I. Amplification condition.
Amplification conditions for the hyper variable regions of the 
16S rRNA using the primer set V2-4-8 and V3-6, 7-9.
Step Temperature Time
Initial denaturation  95°C 10 min
Denaturation 95°C 30 sec
Annealing   x 30 cycles 58°C 20 sec
Extension 72°C 20 sec
Final extension 72°C 7 min
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mitis had an opposite behavior, with a prompt 
reduction in relative abundance at T2. While the 
presence of S. mitis and S. thermophilus progres-
sively increased over time, the levels of S. sangui-
nis had a drastic decreased (Figure 2A). Among 
the most abundant streptococci, the presence of 
Streptococcus australis and S. salivarius enor-
mously increased after seven days of treatment 
and returned to baseline values from day 14 (T3). 
Conversely, even if Streptococcus pseudopneu-
moniae was detected at basal values at one month 
after the end of the probiotic consumption, a peak 
in its abundance was observed at T3 (Figure 2B).
The remaining identified microorganisms were 
grouped in accordance with their aerobic or anaer-
obic metabolism. Concerning the aerobic bacteria, 
the administration of S. salivarius 24SMBc and S. 
oralis 89a seemed not to affect the Haemophilus 
parainfluenzae and Rothia dentocariosa abundanc-
es, which remained stable overtime. Differently, a 
discontinuous trend in the M. catarrhalis abundance 
was found during the experimental time points. In-
deed, after a drop at T3, a gradual recovery was 
observed up to the one month after the end of the 
treatment. A similar increase at T4 was also detected 
in Neisseria perflava (Figure 3A).
Finally, among the anaerobic bacteria, 
Prevotella melaninogenica was the most abun-
dant species detected. The probiotic administra-
tion affected this pathobiont in which a decrease 
was found up to T3 and a return towards basal 
valued at T4. A similar trend as that described for 
corynebacteria was also observed for the remain-
ing representatives of Prevotella ssp. (Figure 3B).
A B
Figure 1. Corynebacteria e staphylococci modulation over time. A, The graph shows the changes in corynebacteria abun-
dance before Rinogermina intake (T1) and 1 week (T2), 2 weeks (T3) and 4 weeks (T4) after the treatment. B, Changes in 
staphylococci abundance before Rinogermina intake (T1) and 1 week (T2), 2 weeks (T3) and 4 weeks (T4) after the treatment.
A B
Figure 2. Streptococci modulation over time. A, The graph shows the changes in less abundant streptococci before Rinoger-
mina intake (T1) and 1 week (T2), 2 weeks (T3) and 4 weeks (T4) after the treatment. B, Changes in more abundant strepto-
cocci before Rinogermina intake (T1) and 1 week (T2), 2 weeks (T3) and 4 weeks (T4) after the treatment.
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Discussion
The human nares physiologically harbor dif-
ferent aerobic and anaerobic commensal microor-
ganisms that compose the nasal microbiota. This 
dynamic ecosystem is strongly influenced by en-
vironmental conditions and by the host itself. The 
bacterial communities and their metabolic prod-
ucts influence the health of their habitat and that of 
the organism in which they live. Indeed, the micro-
biota possesses the capability to reflect the health 
status of the host, and a dysbiosis caused by the 
homeostasis alteration lead to changes that might 
be used as potential diagnostic tools12. For this rea-
son, numerous bacterial isolated from healthy sub-
jects have been proposed as probiotics to restore 
this imbalance. The local administration of fully 
characterized commensal bacteria which presence 
is associated to a healthy state might be beneficial 
for both preventing and treating pathological con-
ditions. Two streptococcal strains, S. salivarius 
24SMBc and S. oralis 89a, have been proposed 
for this purpose as they were isolated from healthy 
individuals during pathological outbreaks and be-
cause they possess desirable characteristics ob-
served in in vitro experiments, such as the ability to 
colonize the respiratory tract and to counteract the 
presence of airborne pathogens13. Previous studies 
underlined the safety and tolerability of the combi-
nation of these two probiotic strains on healthy and 
pathological subjects by evaluating the clinical out-
comes after the administration of the nasal spray 
formulation9,10. However, the impact of Rinoger-
mina on the normal nasal microbiota has not been 
investigated yet. Hence, a metagenomic approach 
for the evaluation of S. salivarius 24SMBc and S. 
oralis 89a on the microbial species composition of 
healthy nostrils was used in this study. The identi-
fication of species can be very challenging and de-
manding because of the high degree of 16S rRNA 
similarities in members of the same genera, but at 
the same time can be an extremely important tool 
to study the microbe-microbe interaction deter-
mined by a peculiar condition14. 
The transient - but not stable - peak in the abun-
dance of S. salivarius after one week is correlated 
to the high percentage of this streptococcal strain 
in Rinogermina. Interestingly, even if it was not no-
ticed a similar trend in the S. oralis abundance, this 
increase might be reflected in other members of the 
S. mitis group, which include S. infantis, S. tiguri-
nus and S. australis. It is well-known that mem-
bers of the S. mitis group are able to influence each 
other by means of the production of competence 
stimulating peptides (CSP) pheromones, which 
also directly control the secretion of streptocine15. 
This effect might contribute to the modulation in 
the number of some observed pathogenic species 
often involved in chronic upper airways infections 
(C. diphtheriae, H. parainfluenzae, M. catarrhalis, 
Prevotella denticola, P. melaninogenica, R. dento-
cariosa, S. aureus and S. pseudopneumoniae)6,16-19. 
Contrary to other members of the mitis group, S. 
pseudopneumoniae had a temporary growth arrest 
probably related to a putative beneficial influence 
of the probiotic administration and the potential in-
hibitory effected exerted by S. oralis, as similarly 
observed in S. pneumoniae20.
Notably, at the end of the follow-up, the action 
of S. salivarius 24SMBc and S. oralis 89a combi-
A B
Figure 3. Other aerobes and anaerobes modulation over time. A, The graph shows the changes in Moraxella catarrhalis, 
Haemophilus parainfluenzae, Dolosigranulum pigrum, Rothia spp., and Neisseria spp. before Rinogermina intake (T1) and 1 
week (T2), 2 weeks (T3) and 4 weeks (T4) after the treatment. B, Changes in Prevotella spp. and Veillonella spp. before Rino-
germina intake (T1) and 1 week (T2), 2 weeks (T3) and 4 weeks (T4) after the treatment.
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nation was appreciable in an important reduction 
of pathogens. In particular, the reduction of the 
abundance of S. aureus during the follow up cor-
relates with the concomitant increase in S. epider-
midis presence. Thus, it can be speculated that the 
nasal colonization of S. aureus was limited by the 
secretion of the extracellular serine protease (Esp) 
by S. epidermidis, which is known to negatively 
affect the mechanisms of adhesion and biofilm 
formation of the above-mentioned pathogen21.
Interestingly, the use of S. salivarius 24SMBc 
and S. oralis 89a resulted in the modulation of the 
presence of Corynebacterium spp. These microor-
ganisms commonly colonize juvenile and adult nasal 
passage, thus its role in the establishment of several 
commensal-pathobiont interactions is not surprising 
14. However, little is known about the molecular inter-
actions of these genera with neighbor bacteria com-
posing the human nasal microbiota. The temporary 
scarceness of the pathogen C. diphtheriae could be 
related to the concomitant predominance of S. sali-
varius, which might exert by a direct inhibitory effect 
on this pathogen, as previously described22. 
Our data might also indicate a positive impact 
of the Rinogermina administration by limiting the 
presence of potential pathogenic anaerobe micro-
organisms such as P. denticola and P. melanino-
genica previously largely recovered in infections 
of upper and lower airways23,24. In fact, of all the 
species present in the upper airway, Streptococci 
showed an antagonist role against Prevotella as 
also reported by Van Essche et al24 describing the 
role of S. salivarius, S. oralis and S. mitis in inhib-
iting the growth of Prevotella intermedia. 
Not only Prevotella spp. was affected by the 
probiotic administration, but also H. parainfluen-
zae and R. dentocariosa displayed a significant 
reduction, with respect to the baseline, 14 days af-
ter the use of S. salivarius 24SMBc and S. oralis 
89a. These beneficial properties were also reflect-
ed in the reduction of M. catarrhalis 14 day after 
the end of the administration. For these reasons, 
it would be interesting to study the influence of 
S. salivarius 24SMBc and S. oralis 89a adminis-
tration in longer time points. A limitation of the 
study was the lack of a control group only treated 
with sterile saline to appreciate possible varia-
tions due to the mechanical action of the fluid. 
Conclusions
Probiotics S. salivarius 24SMBc and S. oralis 
89a were able to positively and temporarily modu-
late the nasal microbiota composition with partic-
ular regards to pathobionts and pathogenic species. 
The positive effects in most of the analyzed species 
seemed to be restricted in a specific temporal win-
dow. Hence it will be important also to elucidate 
the impact of longer administration of Rinogermi-
na, which might result in a more consistent modu-
lation of the nasal microbiota during time.
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